Carcinoma, Small Cell

"Carcinoma, Small Cell" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

An anaplastic, highly malignant, and usually bronchogenic carcinoma composed of small ovoid cells with scanty neoplasm. It is characterized by a dominant, deeply basophilic nucleus, and absent or indistinct nucleoli. (From Stedman, 25th ed; Holland et al., Cancer Medicine, 3d ed, p1286-7)

Descriptor ID	D018288
MeSH Number(s)	C04.557.470.200.380
Concept/Terms	Carcinoma, Small Cell Carcinoma, Small Cell Carcinomas, Small Cell Small Cell Carcinomas Oat Cell Carcinoma Small Cell Carcinoma Carcinoma, Oat Cell Carcinomas, Oat Cell Oat Cell Carcinomas

Below are MeSH descriptors whose meaning is more general than "Carcinoma, Small Cell".

Diseases [C]
Neoplasms [C04]
Neoplasms by Histologic Type [C04.557]
Neoplasms, Glandular and Epithelial [C04.557.470]
Carcinoma [C04.557.470.200]
Carcinoma, Small Cell [C04.557.470.200.380]

Below are MeSH descriptors whose meaning is related to "Carcinoma, Small Cell".

Below are MeSH descriptors whose meaning is more specific than "Carcinoma, Small Cell".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Carcinoma, Small Cell" by people in this website by year, and whether "Carcinoma, Small Cell" was a major or minor topic of these publications.

Bar chart showing 18 publications over 12 distinct years, with a maximum of 3 publications in 1999

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	1	0	1
1998	1	0	1
1999	1	2	3
2000	0	1	1
2003	1	0	1
2005	1	0	1
2006	2	0	2
2007	2	0	2
2010	0	2	2
2011	0	1	1
2018	1	0	1
2020	1	1	2

Below are the most recent publications written about "Carcinoma, Small Cell" by people in Profiles.

Kim IE, Amin A, Wang LJ, Cheng L, Perrino CM. Insulinoma-associated Protein 1 (INSM1) Expression in Small Cell Neuroendocrine Carcinoma of the Urinary Tract. Appl Immunohistochem Mol Morphol. 2020 10; 28(9):687-693.

View in: PubMed
Raibagkar P, Ho D, Gunturu KS, Srinivasan J. Worsening of anti-Hu paraneoplastic neurological syndrome related to anti-PD-1 treatment: Case report and review of literature. J Neuroimmunol. 2020 04 15; 341:577184.

View in: PubMed
Salhab M, Migdady Y, Donahue M, Xiong Y, Dresser K, Walsh W, Chen BJ, Liebmann J. Immunohistochemical expression and prognostic value of PD-L1 in Extrapulmonary small cell carcinoma: a single institution experience. J Immunother Cancer. 2018 05 29; 6(1):42.

View in: PubMed
Owens CL, Fraire AE. Combined carcinoid tumor and squamous cell carcinoma of lung: expanding the spectrum of combined tumors of lung. Int J Surg Pathol. 2011 Apr; 19(2):273-5.

View in: PubMed
Chlebowski RT, Anderson GL, Manson JE, Schwartz AG, Wakelee H, Gass M, Rodabough RJ, Johnson KC, Wactawski-Wende J, Kotchen JM, Ockene JK, O'Sullivan MJ, Hubbell FA, Chien JW, Chen C, Stefanick ML. Lung cancer among postmenopausal women treated with estrogen alone in the women's health initiative randomized trial. J Natl Cancer Inst. 2010 Sep 22; 102(18):1413-21.

View in: PubMed
Blanchard EM, Arnaoutakis K, Hesketh PJ. Lung cancer in octogenarians. J Thorac Oncol. 2010 Jun; 5(6):909-16.

View in: PubMed
Akerley W, McCoy J, Hesketh PJ, Goodwin JW, Bearden JD, Atkins JN, Chansky K, Crowley JJ, Gandara DR. Gemcitabine and irinotecan for patients with untreated extensive stage small cell lung cancer: SWOG 0119. J Thorac Oncol. 2007 Jun; 2(6):526-30.

View in: PubMed
Hesketh PJ, Chansky K, Israel V, Grapski RT, Mekhail TM, Spiridonidis CH, Mills GM, Kelly K, Crowley JJ, Gandara DR. Phase II study of gemcitabine and cisplatin in patients with previously untreated extensive stage small cell lung cancer: Southwest Oncology Group Study 9718. J Thorac Oncol. 2007 May; 2(5):440-4.

View in: PubMed
Hesketh PJ, McCoy J, Dunphy FR, Bearden JD, Weiss GR, Giguere JK, Atkins JN, Dakhil SR, Kelly K, Crowley JJ, Gandara DR. Phase II trial of paclitaxel, carboplatin, and topotecan with G-CSF support in previously untreated patients with extensive stage small cell lung cancer: Southwest Oncology Group 9914. J Thorac Oncol. 2006 Nov; 1(9):991-5.

View in: PubMed
Zhou J, Chen J, Zhong R, Mokotoff M, Shultz LD, Ball ED. Targeting gastrin-releasing peptide receptors on small cell lung cancer cells with a bispecific molecule that activates polyclonal T lymphocytes. Clin Cancer Res. 2006 Apr 01; 12(7 Pt 1):2224-31.

View in: PubMed

People

Explore

Similar Concepts

Top Journals